Is Mode of Presentation of B3 Breast Core Biopsies (Screen-Detected or Symptomatic) a Distinguishing Factor in the Final Histopathologic Result or Risk of Diagnosis of Malignancy?-Reference-Cited by-同舟云学术

Is Mode of Presentation of B3 Breast Core Biopsies (Screen-Detected or Symptomatic) a Distinguishing Factor in the Final Histopathologic Result or Risk of Diagnosis of Malignancy?

Published:2013-08-21 Issue:11 Volume:37 Page:2607-2612
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

MacLean Gael M.,Courtney Stephen P.,Umeh Hilary,Sanjeev Siriathan,McCormick Colin,Smith Brendan M.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-013-2191-6.pdf

Reference27 articles.

1. Rakha E (2011) Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer 129:1417–1424

2. Hayes B (2009) Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol 62:1136–1140

3. El-Sayed M (2008) Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 53:650–657

4. Beral V (2006) Screening for breast cancer in England: past and future. NHS Cancer Screening Programme. www.cancerscreening.nhs.uk

5. Ellis I (2003) External quality assessment scheme for breast screening histopathology. NHS Cancer Screening Programme. www.cancerscreening.nhs.uk

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-Analysis;Journal of the American College of Radiology;2020-10

2. A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases;PLOS ONE;2020-05-21

3. High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis;European Journal of Surgical Oncology;2019-04

4. Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite;Clinical Breast Cancer;2018-12

5. A new risk stratification score for the management of ultrasound-detected B3 breast lesions;The Breast Journal;2018-09-14